First doses of revolutionary R21 vaccine administered to children in Ivory Coast, marking significant progress in fight against malaria

Children in Ivory Coast have started receiving the first doses of a new malaria vaccine, marking a significant milestone in the fight against this deadly disease. The R21 vaccine, developed by the Jenner Institute at the University of Oxford and the Serum Institute of India (SII), costs less than $4 per dose and has shown high efficacy levels in young children, potentially saving up to 500,000 child deaths annually. This affordable vaccine has the potential to make a substantial impact on public health, especially in Africa where malaria remains a leading cause of death, with children under the age of 5 being the most affected.

The rollout of the R21 vaccine is a collaborative effort to combat malaria, with several African countries already receiving doses and more nations authorizing its use. The vaccine will work in conjunction with the RTS,S vaccine, which has shown positive results in reducing mortality rates in previous pilot programs. This combined approach, approved by the World Health Organization (WHO), offers hope for effectively controlling and preventing malaria.

Despite the promising outcomes, challenges lie ahead in distributing millions of doses and ensuring proper training in administering the vaccines, particularly in low-income countries. Nevertheless, the commitment to producing large quantities of the vaccine indicates a step in the right direction towards eradicating malaria-related deaths.

The launch of this vaccination campaign signifies a concerted effort to significantly reduce the impact of malaria on vulnerable populations, emphasizing the importance of preventive measures and innovative solutions in global health initiatives.

How much do you know?

Where was the R21 malaria vaccine developed?

University of Oxford and Serum Institute of India

Johns Hopkins University

Harvard University

Stanford University

How much does the R21 vaccine cost per dose?

Less than $4

$10

$25

$50

Who has shown high efficacy levels in young children?

R21 vaccine

RTS,S vaccine

World Health Organization

Gates Foundation

What region has a high prevalence of malaria making the vaccine crucial?

Africa

Europe

Asia

North America

What is the potential impact of the R21 vaccine on annual child deaths?

Saving up to 500,000 child deaths

Reducing 100,000 child deaths

No impact on child deaths

Increasing child deaths

Which organization has approved the combined approach of the R21 and RTS,S vaccines?

World Health Organization

United Nations

Red Cross

Doctors Without Borders

This question is required